Moderna, Inc. (NASDAQ:MRNA) ranks among the best biotech stocks to buy. Following solid trial results for Moderna, Inc.

Flu and COVID-19 vaccines are being rolled out across Yorkshire as part of a national effort to protect the most vulnerable this winter.

The flu season typically starts in November and peaks over the winter before winding down in March. This year’s vaccination program is being implemented in two phases, and eligible individuals can ...

Nasal sprays are part of a layered defence strategy. For Indians, the key takeaway is cautious optimism. Sprays may help ...

The increased Covid activity comes as the US heads into fall respiratory illness season, which tends to bring a rise in cases ...

Dr. Olivia Kasirye, who led Sacramento County’s response to the COVID-19 pandemic, will retire in March after 14 years as the county’s public health officer and more than two decades of service in the ...

A new executive order mandates Pennsylvania’s executive branch be consistent and unified in allowing vaccine access and ...

The abrupt termination last month of nearly half a billion dollars in US government contracts for mRNA vaccine research ...

Health officials in Nebraska are expressing alarm over declining vaccination rates among children, which they warn could lead ...

The Moderna Innovation and Technology Centre in Harwell, Oxfordshire is now fully operational and Moderna is licensed to ...

The Department of Defense funds biomedical research to ensure military and pandemic preparedness. This includes mRNA vaccine ...

In what has been described as “a rare move for a U.S. public official” to influence vaccine research, Kennedy has called for ...